Tag: Patient Safety

COVID-19: Randomized, double-blind, placebo-controlled, multicenter trial of remdesivir

Editor's Note In this randomized, double-blind, placebo-controlled, multicenter trial of remdesivir for the treatment of COVID-19, remdesivir was not associated with statistically significant clinical benefits. For the analysis, 237 patients were randomly assigned to either a treatment group with remdesivir (158 patients) or placebo (79 patients). Remdesivir use was not…

Read More

By: Judy Mathias
April 30, 2020
Share

Abbott’s new COVID-19 antibody test approved for use across Europe

Editor's Note Abbott’s new COVID-19 antibody test that has 99% sensitivity and specificity has been given CE Mark approval for use across Europe, the April 29 Mass Device reports. The test is 99% accurate in identifying the IgG protein in patients infected by COVID-19, 14 days after symptoms develop. Abbott…

Read More

By: Judy Mathias
April 30, 2020
Share

Study: New immunoassay test detects antibodies against SARS-CoV-2 in 10 minutes

Editor's Note In this proof-of-concept study, a new lateral flow immunoassay developed by researchers from China can quickly detect antibodies against SARS-COV-2, which appear as a bright orange line when placed on a fluorescence reader. The test, which is based on a technique similar to what is used in home…

Read More

By: Judy Mathias
April 30, 2020
Share

Siemens Healthineers’ COVID-19 assay given approval for use in Europe

Editor's Note European regulators have approved Siemens Healthineers’ molecular Fast Track Diagnostics SARS-CoV-2 Assay, which has 100% specificity and sensitivity. The new assay uses real-time polymerase chain reaction (PCR) to detect ribonucleic acid (RNA) from this virus. The company plans to ship more than 1.3 million tests per month worldwide…

Read More

By: Judy Mathias
April 30, 2020
Share

Study estimates healthcare costs, resource use linked to COVID-19

Editor's Note The spread of COVID-19 in the US could result in hundreds of billions of dollars in direct medical costs, according to this study partially funded by the Agency for Healthcare Research and Quality (AHRQ). Using AHRQ data and other sources, researchers developed computer models to simulate the financial…

Read More

By: Judy Mathias
April 29, 2020
Share

OSHA issues guidance on reuse, decontamination of N95 respirators

Editor's Note The Occupational Safety and Health Administration (OSHA) on April 24 issued interim guidance on the reuse and decontamination of N95 and other filtering-facepiece respirators during the COVID-19 pandemic. OSHA notes that the National Institute for Occupational Safety and Health (NIOSH) has identified research that suggests the following methods…

Read More

By: Judy Mathias
April 29, 2020
Share

Surgeons help create process for disinfecting, reusing N95 masks

Editor's Note In this study from BJC HealthCare and Washington University School of Medicine, St Louis, a multidisciplinary team that included surgeons created a new process for disinfecting and reusing N95 masks, using vaporized hydrogen peroxide. The process allows healthcare workers (HCW) to reuse masks up to 20 cycles, and…

Read More

By: Judy Mathias
April 28, 2020
Share

AI tool identifies COVID-19 patients who need ventilators

Editor's Note An artificial intelligence (AI) tool that analyzes CT scans of the chest was 75% accurate in determining COVID-19 patients who required ventilators, the April Radiology Business reports. Researchers at Cleveland’s Case Western Reserve University built the tool using scans and datasets from the web, COVID-19 chest images from…

Read More

By: Judy Mathias
April 28, 2020
Share

Research team develops AI platform to combat COVID-19, infectious diseases

Editor's Note: A research team led by the University of Singapore has developed an artificial intelligence (AI) platform called, “IDentif.AI” (Indentifying Infectious Disease Combination Therapy with Artificial Intelligence) to increase efficiency in the development of treatments that combine several different drugs. The researchers selected 12 drugs that are viable candidates…

Read More

By: Judy Mathias
April 27, 2020
Share

AI system used to predict decline in critically ill COVID-19 patients

Editor's Note: Epic’s deterioration index, an artificial intelligence (AI), machine learning-based system that can predict which patients with COVID-19 could become seriously ill, has been put into use at hospitals nationwide, the April 24 STAT reports. Though normally hospitals would take weeks or months to test a new tool on…

Read More

By: Judy Mathias
April 27, 2020
Share

Join our community

Learn More
Video Spotlight
Live chat by BoldChat